Convalescent Plasma News and Research

RSS
Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

mRNA COVID-19 vaccines induce high antibody titers with significant neutralizing potency in saliva

mRNA COVID-19 vaccines induce high antibody titers with significant neutralizing potency in saliva

The emergence and spread of the SARS-CoV-2 Lambda (B.1.621) variant

The emergence and spread of the SARS-CoV-2 Lambda (B.1.621) variant

SARS-CoV-2 mutations alter dynamics of neutralizing antibodies

SARS-CoV-2 mutations alter dynamics of neutralizing antibodies

Small study suggests a mix-and-match COVID-19 booster produces robust antibody levels

Small study suggests a mix-and-match COVID-19 booster produces robust antibody levels

How does the SARS-CoV-2 Delta variant’s spike drive membrane fusion and immunity evasion?

How does the SARS-CoV-2 Delta variant’s spike drive membrane fusion and immunity evasion?

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

Convalescent plasma does not benefit high-risk COVID-19 outpatients with early symptoms, study shows

Convalescent plasma does not benefit high-risk COVID-19 outpatients with early symptoms, study shows

‘Tainted’ blood: Covid skeptics request blood transfusions from unvaccinated donors

‘Tainted’ blood: Covid skeptics request blood transfusions from unvaccinated donors

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

Data reinforces SAB-185’s potential to neutralize SARS-CoV-2 variants

SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization

SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Study shows COVID-19 organ-specific outcomes depend on anti-spike glycoprotein antibodies

Study shows COVID-19 organ-specific outcomes depend on anti-spike glycoprotein antibodies

Intradermal administration of low-dose mRNA COVID-19 vaccine induces strong immune response, study finds

Intradermal administration of low-dose mRNA COVID-19 vaccine induces strong immune response, study finds

Scientists develop a potent peptide inhibitor of SARS-CoV-2 in vitro

Scientists develop a potent peptide inhibitor of SARS-CoV-2 in vitro

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Combination antibody therapies retain potency against SARS-CoV-2 variants, FDA / HHS research

Past SARS-CoV-2 infection enhances mRNA vaccine-induced neutralization of variants of concern

Past SARS-CoV-2 infection enhances mRNA vaccine-induced neutralization of variants of concern

Study sheds light on immune processes involved in long COVID

Study sheds light on immune processes involved in long COVID

Scientists study how our immune system responds to COVID-19 variants

Scientists study how our immune system responds to COVID-19 variants